JPRN-UMIN000038507
Not yet recruiting
未知
11C-preladenant imaging in Parkinson's disease - 11C-preladenant imaging in Parkinson's disease
Tokyo Metropolitan Institute of Gerontology0 sites20 target enrollmentDecember 1, 2019
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Parkinson'
- Sponsor
- Tokyo Metropolitan Institute of Gerontology
- Enrollment
- 20
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The subjects who cannot undergo MRI. The subject who have chronic dysfunction in the organs. Pregnant or woman who has a chance of pregnant. The subjects who were judged by the clinical investigator to be inappropriate as a participant in this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Withdrawn
Not Applicable
The role of imaging in Parkinson*s disease subtypes: a pilot study .NL-OMON35081eids Universitair Medisch Centrum10
Completed
Not Applicable
Imaging Biomarkers in Parkinson s DiseaseParkinson DiseaseNCT01496599National Institute of Neurological Disorders and Stroke (NINDS)62
Withdrawn
Not Applicable
Molecular and Functional Imaging in SNCA, Parkin and PINK1Parkinson DiseasePARK1PARK2NCT04084509King's College London
Completed
Not Applicable
In vivo imaging of neuroinflammation in Parkinson's disease: A first in human purinergic P2X7 receptor PET study <br>NL-OMON44519Vrije Universiteit Medisch Centrum14
Active, not recruiting
Phase 1
Parkinson’s Disease: PET scan and evaluation of memantines pharmacological effect.(Parkinsons sygdom bedømt med PET skanning, herunder memantins farmakologiske effekt.) - N/AEUCTR2004-004139-74-DKeurologisk afdeling F12